Investors

Creating long-term value
Creating long-term value

News & Events

Date               Event                   Description 
19 Jul 2012 

HY Results 2012

Webcast with financial results for the first 6 months of 2012 

18 Oct 2012Q3 Results 2012

Webcast with financial results for the first 9 months of 2012 

14 Feb 2013FY Results 2012Webcast with financial results for the full year 2012
Learn more about the events

Share price

ATLN SIX Swiss Exchange

At 17:31:17 CEST 16/05/2012
CHF 38,23Up Down image
+0,18 (+0,47%)
 

Key information

Actelion's financial reporting

On 08 May 2012 Actelion presented its strategy for value creation.

To view the webcast please follow the link.

 
View the replay here
 

AGM

AGM to be held on 04 May 2012

Annual General Meeting 2012

The Annual General Meeting of Shareholders will be held on 04 May 2012.

AGM to be held on 04 May 2012

Annual General Meeting 2012

The Annual General Meeting of Shareholders will be held on 04 May 2012.

Financial Information

In CHF million

Q1 2012
Results

Q1 2011
Results

in %
CHF

in %
LC

Net Revenues                           

417.5

528.2

(21)

(18)

Operating Expenses

350.3

363.6

(4)

(2)

Operating Income

67.1

164.7

(59)

(54)

Core Earnings 

107.6

127.9

(16)

(9)

Net income/(Loss)

45.1

146.3

(69)

(64)

Diluted EPS in CHF

0.38

1.20

(68)

(63)

No of shares in calculation

118.9

122.1

-

-

Contact

Investor Relations
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil
Switzerland
Phone:+41 61 565 62 62
Fax:+41 61 565 65 07